Weidong Xiao Selected Research

6-formylindolo(3,2-b)carbazole

3/2019	Aryl hydrocarbon receptor activation modulates γδ intestinal intraepithelial lymphocytes and protects against ischemia/reperfusion injury in the murine small intestine.
1/2019	Aryl hydrocarbon receptor activation alleviates dextran sodium sulfate-induced colitis through enhancing the differentiation of goblet cells.
10/2018	AhR activation protects intestinal epithelial barrier function through regulation of Par-6.
5/2018	6-Formylindolo(3,2-b)carbazole induced aryl hydrocarbon receptor activation prevents intestinal barrier dysfunction through regulation of claudin-2 expression.
3/2018	Aryl hydrocarbon receptor activation maintained the intestinal epithelial barrier function through Notch1 dependent signaling pathway.
2/2018	Aryl hydrocarbon receptor inhibits inflammation in DSS‑induced colitis via the MK2/p‑MK2/TTP pathway.
1/2018	Aryl Hydrocarbon Receptor Activation Modulates Intestinal Epithelial Barrier Function by Maintaining Tight Junction Integrity.
5/2016	The AhR is involved in the regulation of LoVo cell proliferation through cell cycle-associated proteins.
1/2016	Aryl Hydrocarbon Receptor Activation in Intestinal Obstruction Ameliorates Intestinal Barrier Dysfunction Via Suppression of MLCK-MLC Phosphorylation Pathway.
7/2015	Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weidong Xiao Research Topics

Disease

18	Neoplasms (Cancer) 06/2022 - 06/2003
13	Hemophilia A (Haemophilia) 03/2022 - 06/2008
12	Colitis 05/2022 - 07/2015
11	Inflammation (Inflammations) 05/2022 - 10/2014
10	Hypoxia (Hypoxemia) 01/2022 - 01/2014
6	Infections 06/2022 - 01/2017
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 07/2017
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2022 - 01/2016
5	Hemophilia B (Haemophilia B) 01/2021 - 01/2004
4	Carcinogenesis 10/2018 - 08/2009
4	Atrophy 05/2017 - 05/2014
3	Ischemia 03/2019 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2019 - 08/2009
3	Stomach Neoplasms (Stomach Cancer) 05/2018 - 05/2015
2	Carcinoma (Carcinomatosis) 08/2021 - 01/2018
2	Neoplasm Metastasis (Metastasis) 08/2021 - 07/2017
2	Necrosis 06/2021 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 10/2018
2	Liver Neoplasms (Liver Cancer) 03/2019 - 06/2003
2	Wounds and Injuries (Trauma) 01/2019 - 11/2017
2	Pain (Aches) 05/2018 - 11/2017
2	Body Weight (Weight, Body) 08/2017 - 07/2008
2	Flatulence 06/2015 - 05/2015
1	Emerging Communicable Diseases (Emerging Infectious Diseases) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Anastomotic Leak 01/2022
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Blister (Bulla) 06/2021
1	Splenomegaly 04/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2021
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021
1	Sepsis (Septicemia) 01/2021
1	Invasive Fungal Infections 01/2021

Drug/Important Bio-Agent (IBA)

10	Factor VIII (Coagulation Factor VIII)IBA 03/2022 - 06/2008
10	6-formylindolo(3,2-b)carbazoleIBA 03/2019 - 07/2015
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2014
6	Dextran SulfateIBA 05/2022 - 07/2015
6	Dextrans (Dextran)FDA Link 06/2020 - 02/2018
6	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 03/2019 - 07/2015
4	SodiumIBA 06/2020 - 02/2018
3	Biomarkers (Surrogate Marker)IBA 02/2021 - 01/2019
3	Factor IX (Coagulation Factor IX)FDA LinkGeneric 01/2021 - 01/2004
3	CateninsIBA 11/2020 - 07/2017
3	carbazoleIBA 10/2018 - 07/2015
3	CytokinesIBA 02/2018 - 05/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2022 - 11/2015
2	Small Interfering RNA (siRNA)IBA 05/2022 - 05/2014
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 02/2018
2	Antiviral Agents (Antivirals)IBA 01/2022 - 11/2013
2	Capsid Proteins (Capsid Protein)IBA 12/2021 - 05/2011
2	OccludinIBA 01/2021 - 01/2015
2	Tight Junction ProteinsIBA 06/2020 - 01/2014
2	Butyrates (Butyrate)IBA 06/2020 - 01/2020
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 01/2019
2	salicylhydroxamic acid (SHAM)IBA 03/2019 - 11/2013
2	EnzymesIBA 01/2019 - 08/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 08/2013
2	ImmunosorbentsIBA 01/2019 - 08/2014
2	Protein Kinases (Protein Kinase)IBA 10/2018 - 05/2014
2	LigandsIBA 05/2018 - 07/2015
2	Pharmaceutical PreparationsIBA 03/2018 - 11/2013
2	CathelicidinsIBA 01/2018 - 01/2016
2	Complementary DNA (cDNA)IBA 03/2009 - 06/2008
1	3-(2'-pyridyldithio)benzyldiazoacetate (MPDA)IBA 05/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2022
1	catechol (pyrocatechol)IBA 05/2022
1	polydopamineIBA 05/2022
1	Therapeutic UsesIBA 05/2022
1	N-succinimidyl 3-(2-pyridyldithio)propionate (SPDP)IBA 04/2022
1	Transaminases (Aminotransferases)IBA 03/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Circular RNAIBA 01/2022
1	IronIBA 01/2022
1	Untranslated RNA (Noncoding RNA)IBA 01/2022
1	VaccinesIBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 06/2021
1	CitrullineIBA 02/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 02/2021
1	2- (4- (2- carboxyethyl)phenethylamino)- 5'- N- ethylcarboxamidoadenosineIBA 01/2021
1	EndotoxinsIBA 01/2021
1	Ointments (Pastes)IBA 01/2021
1	Gemcitabine FDA Link 01/2021
1	MannansIBA 01/2021

Therapy/Procedure

11	Therapeutics 06/2022 - 06/2003
7	Length of Stay 01/2021 - 05/2015
3	Hepatectomy 03/2019 - 01/2017
3	Gastrectomy 05/2018 - 05/2015
3	Total Parenteral Nutrition 05/2017 - 05/2014
2	Ileostomy 06/2022 - 01/2022
2	Pancreaticoduodenectomy 04/2022 - 06/2019
2	Pancreatectomy 04/2022 - 01/2016
2	Drug Therapy (Chemotherapy) 08/2021 - 12/2018
2	Operative Time 01/2021 - 05/2015
2	Negative-Pressure Wound Therapy 01/2019 - 11/2017
2	Enteral Nutrition (Feeding, Tube) 05/2017 - 11/2015
2	Parenteral Nutrition 05/2017 - 11/2015
2	Gastroenterostomy 06/2015 - 05/2015
1	Immunomodulation 03/2022
1	Splenectomy 04/2021